{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:12:16Z","timestamp":1778551936326,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00228-026-04069-9","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:55:42Z","timestamp":1778028942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Examining the risk of neurotoxicity in patients who receive unadjusted doses of oral beta-lactams in renal insufficiency: a retrospective cohort study"],"prefix":"10.1007","volume":"82","author":[{"given":"Noah","family":"Zlotnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip W.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Palmay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome A.","family":"Leis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Daneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Elligsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"4069_CR1","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario) (2023) Opportunities in public health to improve antibiotic use in Ontario"},{"key":"4069_CR2","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.2215\/CJN.08140718","volume":"14","author":"RF Eyler","year":"2019","unstructured":"Eyler RF, Shvets K (2019) Clinical pharmacology of antibiotics. Clin J Am Soc Nephrol 14:1080\u20131090. https:\/\/doi.org\/10.2215\/CJN.08140718","journal-title":"Clin J Am Soc Nephrol"},{"key":"4069_CR3","unstructured":"Amoxicillin 500\u00a0mg Capsules - Summary of Product Characteristics (SmPC) - (emc) | 13501. https:\/\/www.medicines.org.uk\/emc\/product\/13501\/smpc. Accessed 20 Apr 2026"},{"key":"4069_CR4","unstructured":"Co-amoxiclav 500\u00a0mg \/125\u00a0mg film-coated Tablets - Summary of Product Characteristics (SmPC) - (emc) | 4347. https:\/\/www.medicines.org.uk\/emc\/product\/4347\/smpc. Accessed 20 Apr 2026"},{"key":"4069_CR5","unstructured":"Cefuroxime 250\u00a0mg tablets - Summary of Product Characteristics (SmPC) - (emc) | 426. https:\/\/www.medicines.org.uk\/emc\/product\/426\/smpc. Accessed 20 Apr 2026"},{"key":"4069_CR6","unstructured":"Canadian Pharmacists Association (2019) Cephalexin (CPhA monograph). In: CPS. https:\/\/cps.pharmacists.ca\/. Accessed 29 Oct 2025"},{"key":"4069_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11091190","volume":"11","author":"C Smit","year":"2022","unstructured":"Smit C, Sen S, Von Dach E et al (2022) Steering away from current amoxicillin dose reductions in hospitalized patients with impaired kidney function to avoid subtherapeutic drug exposure. Antibiotics 11:1190. https:\/\/doi.org\/10.3390\/antibiotics11091190","journal-title":"Antibiotics"},{"key":"4069_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159\u2013177. https:\/\/doi.org\/10.1086\/510393","journal-title":"Clin Infect Dis"},{"key":"4069_CR9","unstructured":"The Sunnybrook Health Sciences Centre Antimicrobial Stewardship Team Antimicrobial Stewardship Handbook https:\/\/sunnybrook.ca\/antimicrobialstewardship. Accessed 29 Oct 2025"},{"key":"4069_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000446","volume":"3","author":"EF Barreto","year":"2021","unstructured":"Barreto EF, Webb AJ, Pais GM et al (2021) Setting the beta-lactam therapeutic range for critically ill patients: is there a floor or even a ceiling? Crit Care Explor 3:e0446. https:\/\/doi.org\/10.1097\/CCE.0000000000000446","journal-title":"Crit Care Explor"},{"key":"4069_CR11","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/jac\/dkx209","volume":"72","author":"S Imani","year":"2017","unstructured":"Imani S, Buscher H, Marriott D et al (2017) Too much of a good thing: a retrospective study of \u03b2-lactam concentration-toxicity relationships. J Antimicrob Chemother 72:2891\u20132897. https:\/\/doi.org\/10.1093\/jac\/dkx209","journal-title":"J Antimicrob Chemother"},{"key":"4069_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/0028-3908(89)90030-0","volume":"28","author":"A De Sarro","year":"1989","unstructured":"De Sarro A, De Sarro GB, Ascioti C, Nistic\u00f3 G (1989) Epileptogenic activity of some beta-lactam derivatives: structure-activity relationship. Neuropharmacology 28:359\u2013365. https:\/\/doi.org\/10.1016\/0028-3908(89)90030-0","journal-title":"Neuropharmacology"},{"key":"4069_CR13","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3109\/0886022X.2013.794684","volume":"35","author":"J Zhang","year":"2013","unstructured":"Zhang J, Huang C, Li H et al (2013) Antibiotic-induced neurotoxicity in dialysis patients: a retrospective study. Ren Fail 35:901\u2013905. https:\/\/doi.org\/10.3109\/0886022X.2013.794684","journal-title":"Ren Fail"},{"key":"4069_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1856-1","volume":"21","author":"LE Payne","year":"2017","unstructured":"Payne LE, Gagnon DJ, Riker RR et al (2017) Cefepime-induced neurotoxicity: a systematic review. Critical Care 21:276. https:\/\/doi.org\/10.1186\/s13054-017-1856-1","journal-title":"Critical Care"},{"key":"4069_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-231875","volume":"13","author":"R Adams","year":"2020","unstructured":"Adams R, Chopra P, Miranda R, Calderon A (2020) Ertapenem-induced encephalopathy. BMJ Case Rep 13:e231875. https:\/\/doi.org\/10.1136\/bcr-2019-231875","journal-title":"BMJ Case Rep"},{"key":"4069_CR16","unstructured":"Canadian Pharmacists Association (2020) Amoxicillin (CPhA monograph). In: CPS. https:\/\/cps.pharmacists.ca\/. Accessed 29 Oct 2025"},{"key":"4069_CR17","unstructured":"Sanis Health Inc (2025) Amoxicillin and Clavulanate Potassium Tablets: Product Monograph. https:\/\/dis-prod.assetful.loblaw.ca\/content\/dam\/loblaw-companies-limited\/creative-assets\/sanis\/2021\/leaflets\/Amoxicillin-Clav-leaflet-06-10-2025.pdf. Accessed 29 Oct 2025"},{"key":"4069_CR18","unstructured":"GlaxoSmithKline I (2017) Product Monograph Cefuroxime Axetil. https:\/\/pdf.hres.ca\/dpd_pm\/00039714.PDF. Accessed 29 Oct 2025"},{"key":"4069_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4212\/cjhp.v65i1.1101","volume":"65","author":"M Elligsen","year":"2012","unstructured":"Elligsen M, Walker SAN, Simor A, Daneman N (2012) Prospective audit and feedback of antimicrobial stewardship in critical care: program implementation, experience, and challenges. Can J Hosp Pharm 65:31\u201336. https:\/\/doi.org\/10.4212\/cjhp.v65i1.1101","journal-title":"Can J Hosp Pharm"},{"key":"4069_CR20","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C et al (2004) New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57:1288\u20131294. https:\/\/doi.org\/10.1016\/j.jclinepi.2004.03.012","journal-title":"J Clin Epidemiol"},{"key":"4069_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239\u2013245. https:\/\/doi.org\/10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"4069_CR22","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385:1737\u20131749. https:\/\/doi.org\/10.1056\/NEJMoa2102953","journal-title":"N Engl J Med"},{"key":"4069_CR23","unstructured":"Core Team R R: A language and environment for statistical computing"},{"key":"4069_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12028-022-01442-1","volume":"37","author":"NA Haddad","year":"2022","unstructured":"Haddad NA, Schreier DJ, Fugate JE et al (2022) Incidence and predictive factors associated with beta-lactam neurotoxicity in the critically ill: a retrospective cohort study. Neurocrit Care 37:73\u201380. https:\/\/doi.org\/10.1007\/s12028-022-01442-1","journal-title":"Neurocrit Care"},{"key":"4069_CR25","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.4103\/jfmpc.jfmpc_831_21","volume":"10","author":"AK Shukla","year":"2021","unstructured":"Shukla AK, Jhaj R, Misra S et al (2021) Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions. J Fam Med Prim Care 10:3303\u20133308. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_831_21","journal-title":"J Fam Med Prim Care"},{"key":"4069_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.11613\/BM.2014.003","volume":"24","author":"S Sperandei","year":"2014","unstructured":"Sperandei S (2014) Understanding logistic regression analysis. Biochem Med 24:12\u201318. https:\/\/doi.org\/10.11613\/BM.2014.003","journal-title":"Biochem Med"},{"key":"4069_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ijrobp.2021.08.007","volume":"112","author":"EC Zabor","year":"2022","unstructured":"Zabor EC, Reddy CA, Tendulkar RD, Patil S (2022) Logistic regression in clinical studies. Int J Radiat Oncol Biol Phys 112:271\u2013277. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.08.007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4069_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/aje\/kwf215","volume":"157","author":"JA Hanley","year":"2003","unstructured":"Hanley JA, Negassa A, Edwardes M, Forrester JE (2003) Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157:364\u2013375. https:\/\/doi.org\/10.1093\/aje\/kwf215","journal-title":"Am J Epidemiol"},{"key":"4069_CR29","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1002\/sim.10260","volume":"43","author":"PC Austin","year":"2024","unstructured":"Austin PC (2024) A comparison of variance estimators for logistic regression models estimated using generalized estimating equations (GEE) in the context of observational health services research. Stat Med 43:5548\u20135561. https:\/\/doi.org\/10.1002\/sim.10260","journal-title":"Stat Med"},{"key":"4069_CR30","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.chest.2020.03.014","volume":"158","author":"X Wang","year":"2020","unstructured":"Wang X, Kattan MW (2020) Cohort studies: Design, analysis, and reporting. Chest 158:S72\u2013S78. https:\/\/doi.org\/10.1016\/j.chest.2020.03.014","journal-title":"Chest"},{"key":"4069_CR31","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario) (2016) Antimicrobial Stewardship Strategy. Intravenous to oral conversion"},{"key":"4069_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.cmi.2022.10.004","volume":"29","author":"K Mponponsuo","year":"2023","unstructured":"Mponponsuo K, Brown KA, Fridman DJ et al (2023) Highly versus less bioavailable oral antibiotics in the treatment of Gram-negative bloodstream infections: a propensity-matched cohort analysis. Clin Microbiol Infect 29:490\u2013497. https:\/\/doi.org\/10.1016\/j.cmi.2022.10.004","journal-title":"Clin Microbiol Infect"},{"key":"4069_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab434","volume":"8","author":"EL Heil","year":"2021","unstructured":"Heil EL, Bork JT, Abbo LM et al (2021) Optimizing the management of uncomplicated Gram-Negative bloodstream infections: Consensus guidance using a modified Delphi process. Open Forum Infect Dis 8:ofab434. https:\/\/doi.org\/10.1093\/ofid\/ofab434","journal-title":"Open Forum Infect Dis"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04069-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04069-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:45:57Z","timestamp":1778550357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04069-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4069"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04069-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}